South Africa Deputy President Meets India's VP Radhakrishnan in New Delhi

South Africa's Deputy President met Vice President Radhakrishnan of India at Hyderabad House in New Delhi on Thursday, launching a bilateral partnership the two governments described as a direct investment in Africa's development future. The meeting took place ahead of the G20 Summit and produced agreements covering pharmaceutical manufacturing, infrastructure financing, and energy cooperation worth a combined $2.4 billion in committed projects across the continent.

Meeting Sets Ambitious Agenda for South-South Cooperation

The Deputy President arrived in New Delhi on Wednesday evening and held bilateral talks that stretched over four hours. Officials from both delegations described the discussions as frank and productive, covering not only trade but also health security, digital infrastructure, and continental peacekeeping. Radhakrishnan told reporters afterward that India views its partnership with South Africa as foundational to New Delhi's broader outreach to Africa. "The relationship between our two nations extends far beyond bilateral trade," he said. "It is a commitment to the collective advancement of the Global South."

South Africa's Ministry of International Relations and Cooperation confirmed the Deputy President had requested the meeting specifically to align Indian development financing with Pretoria's own infrastructure priorities under the Presidential Infrastructure Programme. Trade and Investment South Africa, the country's investment promotion agency, seconded a delegation official to accompany the Deputy President and facilitate discussions with Indian private-sector firms.

Why the G20 Context Gives This Meeting Extra Weight

The timing matters. South Africa held the BRICS chairmanship and was preparing for the G20 Leaders' Summit in New Delhi under India's presidency. Pretoria has consistently used multilateral platforms to advocate for greater African representation in global governance structures, particularly at the United Nations Security Council. The meeting with Radhakrishnan gave the Deputy President a direct channel to coordinate messaging ahead of those high-stakes negotiations.

India, meanwhile, was pursuing its own agenda as G20 president, seeking to position the forum as a platform for emerging economies rather than a forum dominated by Western powers. Radhakrishnan noted that South Africa — as Africa's only G20 member — served as an essential bridge between the Global South and the world's largest economies.

Continental Voice at the Table

African Union Summit delegates in Addis Ababa have repeatedly called for the continent to speak with a single voice on trade, climate finance, and debt relief. South Africa's Deputy President told Radhakrishnan that Pretoria was committed to representing AU positions forcefully during the G20 summit. Both sides agreed to establish a joint working group on multilateral affairs that would consult before major international forums.

India-Africa Trade Corridors Come Into Sharper Focus

Bilateral trade between India and South Africa reached $15.1 billion in the most recent fiscal year, according to figures released by India's Ministry of Commerce and Industry. India exports pharmaceutical products, automobiles, and information technology services to South Africa, while importing coal, gold, and precious stones. Both governments want to shift the composition of that trade toward higher-value goods and fewer raw commodities.

The two sides signed memoranda of understanding covering three priority sectors: health technology, renewable energy, and digital connectivity. The health MOU specifically aims to expand the production of generic medicines in South Africa, where Indian pharmaceutical firms already operate manufacturing facilities serving the broader Southern African Development Community region.

Health Cooperation Anchors the Agreements

Pharmaceuticals were at the centre of the discussions. India's generic drug industry supplies an estimated 50 percent of Africa's antiretrovirals and over 40 percent of its tuberculosis medications. The Serum Institute of India, which manufactured COVID-19 vaccines distributed across Africa, has already invested in production facilities in South Africa's Gauteng province. Thursday's agreements expand that footprint by committing to joint clinical trials and the local production of cancer drugs.

Radhakrishnan announced that India would allocate an additional $150 million through the India-Africa Development Fund to support health infrastructure projects in SADC member states. South Africa's Deputy President welcomed the commitment, calling it a direct response to the gaps exposed during the COVID-19 pandemic across the continent.

Infrastructure Financing Targets Transport and Energy

Beyond health, the two governments signed off on infrastructure commitments worth approximately $2.25 billion. Indian firms have expressed interest in South Africa's rail modernisation programme, which Pretoria values at $4.8 billion over five years. Roads connecting Gauteng to KwaZulu-Natal featured prominently in the talks, with both sides acknowledging that poor logistics infrastructure remains one of the biggest barriers to intra-African trade.

The IBSA Fund — a trilateral development initiative involving India, Brazil, and South Africa — will channel $30 million into renewable energy projects in rural areas of Limpopo and Mpumalanga provinces. Radhakrishnan described the fund as a model for how emerging economies can pool resources to support development without the conditionalities attached to Western-backed financing.

What This Means for West Africa and Nigeria

Nigerian trade officials in Abuja will be watching the outcomes closely. India is Nigeria's largest crude oil customer, purchasing roughly 35 percent of Nigeria's daily oil output. Any expansion of Indian investment in South African logistics and infrastructure has downstream implications for how West African goods reach Indian markets through Cape Town and Durban ports.

Pharmaceutical supply chains are another concern. Nigeria's National Primary Health Care Development Agency relies heavily on Indian generic manufacturers for vaccines and essential medicines. If Indian firms redirect production capacity toward South Africa under bilateral agreements, Abuja may need to renegotiate supply arrangements or accelerate its own pharmaceutical manufacturing strategy.

What Comes Next

The joint working group on health and infrastructure is expected to present its first progress report within 90 days. A follow-up ministerial conference is tentatively scheduled for February in Pretoria, where both governments will attempt to convert Thursday's MOUs into firm contract awards. Indian Prime Minister Modi's office confirmed that the Prime Minister would receive the South African Deputy President separately on the margins of the G20 Summit, where heads of government are expected to endorse the bilateral agreements in a joint communiqué.